EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

L26/P-804 Adiposity and metabolic profiles in offspring of mothers with polycystic ovary syndrome: a systematic review and meta-analysis

G. Tan, S.Q. Wei, J. Tan, M.H. Dahan, M. Cao, S.L. Tan

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1131 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von G. Tan und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Do children born to mothers with polycystic ovary syndrome (PCOS) exhibit altered adiposity and metabolic profiles compared with offspring of women without PCOS? Summary answer Offspring of mothers with PCOS show higher adiposity, impaired glucose metabolism, and elevated insulin levels, indicating increased long-term metabolic risk. What is known already PCOS is a common endocrine disorder associated with insulin resistance, type 2 diabetes, and adverse metabolic outcomes in affected women. Emerging evidence suggests that in-utero exposure to maternal hyperandrogenism, metabolic dysfunction, or inflammation may influence long-term metabolic health in offspring. However, findings across studies have been inconsistent. A comprehensive synthesis of available literature is needed to clarify whether maternal PCOS is associated with metabolic indicators in offspring. Study design, size, duration This study was a systematic review and meta-analysis conducted in accordance with PRISMA guidelines and Cochrane methods. The protocol was prospectively registered in PROSPERO (CRD420251058821). Eligible studies were comparative designs assessing adiposity and metabolic outcomes in offspring of mothers with PCOS. The exposure was maternal PCOS. Outcomes included body mass index (BMI), glucose metabolism, insulin levels, insulin resistance, and metabolic biomarkers. Study size and duration reflected the scope and follow-up periods of the included cohorts. Participants/materials, setting, methods Participants were offspring of mothers with or without PCOS. PubMed, Embase, and the Cochrane Library were searched from inception to December 2025 for studies evaluating associations between maternal PCOS and offspring metabolic parameters. Study quality was assessed using the Newcastle–Ottawa Scale. Random-effects models were used to estimate the pooled risk ratios or standardized mean differences with 95% confidence intervals. Heterogeneity was evaluated using the X² test and quantified with the I² statistic. Main results and the role of chance Twenty-six studies were included, encompassing 9,097,136 offspring and an average follow-up of 9.9 years. Offspring of mothers with PCOS had significantly higher BMI (SMD 0.20, 95% CI 0.06–0.35; I²=68%; 17 studies). Markers of glucose and insulin metabolism were also elevated, including fasting insulin (SMD 0.31, 95% CI 0.03–0.60; I²=79%; 15 studies), 2-hour glucose (SMD 0.31, 95% CI 0.03–0.60; I²=71%; 10 studies), and 2-hour insulin (SMD 1.51, 95% CI 0.78–2.24; I²=93%; 12 studies). Homeostatic model assessment of insulin resistance (HOMA-IR) showed a non-significant trend toward higher insulin resistance (SMD 0.19, 95% CI –0.16 to 0.55; I²=78%; 8 studies). Fasting c-peptide levels were modestly increased (SMD 0.09, 95% CI 0.04–0.14; I²=0%; 2 studies). Offspring of mothers with PCOS were also more likely to be obese compared with offspring of mothers without PCOS (RR 1.26, 95% CI 1.05–1.50; I²=78%; 4 studies). Limitations, reasons for caution Heterogeneity across studies was considerable for several outcomes, and some endpoints were reported by only a small number of studies. In addition, residual confounding at the time of assessment may have influenced the observed associations. Wider implications of the findings These findings suggest that children born to mothers with PCOS face an elevated risk of increased adiposity, adverse metabolic profiles, and obesity. This underscores the importance of early metabolic follow-up and the implementation of targeted preventive strategies throughout childhood. Trial registration number Yes

Zitieren

APA

Tan, G., Wei, S., Tan, J., Dahan, M., Cao, M., & Tan, S. (2026). L26/P-804 Adiposity and metabolic profiles in offspring of mothers with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1131

Vancouver

Tan G, Wei S, Tan J, Dahan M, Cao M, Tan S. L26/P-804 Adiposity and metabolic profiles in offspring of mothers with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1131

BibTeX
@article{Tan2026,
  author = {Tan, G. and Wei, S.Q. and Tan, J. and Dahan, M.H. and Cao, M. and Tan, S.L.},
  title = {L26/P-804 Adiposity and metabolic profiles in offspring of mothers with polycystic ovary syndrome: a systematic review and meta-analysis},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1131}
}
Kostenlos starten →